Recent meta-analyses of structural and functional neuroimaging studies are converging on a collective core of brain regions affected across most psychiatric disorders, centered on the dorsal anterior cingulate cortex (dACC) and anterior insula. These nodes correspond well to an anterior cingulo-insular (aCIN) or 'salience' network, and stand at a crossroads within the functional architecture of the brain, acting as a switch to deploy other major functional networks according to motivational demands and environmental constraints. Therefore, disruption of these 'linchpin' areas may be disproportionately disabling, even when other networks remain intact. These regions may represent promising targets for a new generation of anatomically directed brain stimulation treatments. Here, we review the potential of the psychiatric core areas as targets for therapeutic brain stimulation in psychiatric disease.
Neurology and Psychiatry: An Intuitive Cartesian Divide
While most organs have one dedicated medical specialty, the brain has been divided into two: neurology and psychiatry. For a variety of historical reasons (see [1] for an interesting review), these two specialties have diverged over the course of the 20th century, and today view each other as separate and distinct. Classically, neurology has laid claim to disorders with identifiable 'organic' lesions in the central nervous system, leaving psychiatry to focus on disorders variously described as 'functional', 'psychogenic', or 'supratentorial' in origin, which have historically lacked readily identifiable lesions [2] .
Yet, the schism cannot be neatly explained simply in terms of the presence or absence of brain pathology. Many brain disorders with well-established neuropathological abnormalities [e.g., bipolar disorder (BP), schizophrenia (SCZ), and obsessive-compulsive disorder (OCD)] are studied almost exclusively in psychiatric journals. Conversely, other brain disorders with wellestablished effects on mood, behavior, and social interaction (e.g., Huntington's disease, Alzheimer's and Parkinson's dementia, and multiple sclerosis) are overwhelmingly allocated toward neurological journals ( Figure 1 ).
The polarization of brain medicine into two specialties may in part reflect an intuitive Cartesian dualism in human psychology. Children intuitively accept that certain mental functions, such as perception, planning, or mental calculation, require the brain; however, other functions, such as emotion, desire, belief, or pretense, are independent of the physical organ [3] . Related studies have demonstrated that even adults struggle to acquire scientific knowledge that clashes with
Trends
The structural and functional correlates of most major psychiatric disorders are becoming increasingly well characterized, owing to expanding databases of neuroimaging studies and new quantitative meta-analytic techniques.
A 'common core' of areas is affected across most categories of psychiatric illness; key nodes include the dACC and anterior insula.
This common core corresponds well to a one of the resting-state networks of the brain, known as the aCIN or 'salience' network; standing in a 'crossroads' position in the network architecture of the brain, it is active during behavioral self-control, emotion regulation, and social cognition.
The common core network may be amenable to therapeutic brain stimulation via repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS). Its nodes may represent a promising target for future studies of therapeutic brain stimulation.
the innate intuitions of childhood, and tend to revert to intuition for unfamiliar scenarios [4] . Thus, one intriguing possibility is that early failures to identify structural lesions for certain brain disorders, coupled with an innate human reluctance to ascribe certain mental functions to the organ itself, allowed two separate disciplines of brain medicine to emerge. This resulted in the current situation: a Cartesian divide between neurology, for disorders of the 'wires', and psychiatry, for disorders of the 'psyche'.
'Where is the Lesion?' in Psychiatry: New Clues from Neuroimaging
Intuitions of dualism aside, it is now clearer than ever that disorders of the 'psyche' are also disorders of the wiring. Since the 1980s, psychiatric neuropathology became amenable to in 
(B) (A)
Publication distribution for prevalent brain disorders vivo study, thanks to non-invasive, high-resolution neuroimaging. The structural neuroimaging technique of voxel-based morphometry (VBM), developed during the late 1990s [5] , has been particularly productive for localizing psychiatric neuropathology. To date, hundreds of 'firstwave' VBM studies have compared gray matter structure in healthy controls versus patients with psychiatric illnesses.
To sift this wealth of data, researchers have developed quantitative meta-analytic algorithms, such as activation likelihood estimation (ALE) [6, 7] , which enable robust statistical inferences about the spatial consistency of reported abnormalities, across combined samples of hundreds of patients. Over the past 5 years, nearly 100 'second-wave' VBM meta-analyses have been reported. Within psychiatry, the first reports appeared for SCZ [8, 9] , followed swiftly by BD [10, 11] , OCD [12, 13] , autism spectrum disorders (ASD) [14, 15] , major depression (MDD) [16, 17] , attention deficit hyperactivity disorder (ADHD) [8, 9] , post-traumatic stress disorder (PTSD) [18, 19] , panic disorder (PD) [18, 20] , generalized anxiety disorder (GAD) [20] , social anxiety disorder (SAD) [20] , substance dependence disorders, including alcohol [21] and stimulants [22] , and eating disorders, such as anorexia nervosa [23] . As of 2015, this literature now offers a first-draft map of consistently observed structural abnormalities for almost every major psychiatric disorder in the Diagnostic and Statistical Manual.
Recently, the VBM literature has begun a 'third-wave' phase of integration, by performing comparative quantitative meta-analyses not only across studies within a disorder, but also across disorders themselves [20, 24, 25] . One recent study applied these methods to address the distinction between neurological and psychiatric disorders directly [24] . The authors surveyed a range of neurological disorders, including several varieties of movement disorder, Alzheimer's and frontotemporal dementia, amyotrophic lateral sclerosis, dyslexia, and temporal lobe epilepsy. Not surprisingly, VBM lesions in neurological disorders extended across diverse brain regions, including sensorimotor cortex, anterior cingulate and insula, striatum, hippocampus, and thalamus. By contrast, psychiatric disorders (SCZ, BD, OCD, PD, PTSD, ADHD, ASD, and anorexia) showed a more restricted pattern of VBM changes involving the anterior cingulate, anterior insula, head of the caudate nucleus, putamen, and anterior hippocampus and amygdala. A direct comparison found more involvement of medial prefrontal cortex, anterior and posterior cingulate, superior frontal gyrus, and occipital cortex in psychiatric versus neurological disorders ( Figure 2A) . Thus, the VBM correlates of psychiatric illness appear to be at least partially distinct from (and certainly a more restricted set of) the more diverse set of areas seen across neurological conditions.
Regarding common substrates of psychiatric illnesses, one recent study examined 24 VBM studies of anxiety disorders, surveying GAD, SAD, PD with and without agoraphobia, and specific phobias [20] . Meta-analytic mapping revealed a pattern of overlapping gray matter reductions in the bilateral pregenual cingulate cortex, right striatum, and right anterior insula, with similar reductions in the left striatum and anterior insula also appearing in those patients who were drug naïve ( Figure 2B ).
Another recent study reported the remarkable finding of a common neural substrate across multiple categories of psychiatric illness [25] . Here, the authors used ALE methods to combine 193 studies of mood, anxiety, psychotic, and substance-use disorders in >7000 patients. By examining different categories of illness separately, the authors identified both common and distinctive substrates. For example, psychotic disorders involved a pattern of gray matter loss extending across medial prefrontal regions, insula, thalamus, and amygdala, as well as gray matter increases in the left and right striatum. Among nonpsychotic disorders, the 'internalizing' disorders of OCD, anxiety disorders, and MDD showed greater gray matter loss in hippocampus and amygdala that were in contrast to 'externalizing' disorders, such as substance abuse.
Yet, there was also a common substrate appearing across every category of disorder: gray matter volume reductions in the left and right anterior insula, and the dACC ( Figure 2C ). Although each illness category also had its own unique neural correlates, these regions appeared consistently across all psychiatric disorders surveyed. Thus, the emerging picture from structural neuroimaging is that psychiatric disorders do indeed have 'organic' correlates that can be consistently identified from sufficiently large samples, and that these correlates may be a distinct subset of regions that are contained within, and do not entirely overlap with, the more diverse set of areas implicated in neurological illnesses.
A Functional Context for the 'Common Core' of Psychiatric Illness
What functions might the psychiatric 'common core' regions serve? The functional neuroimaging literature now includes tens of thousands of studies of cognition and behavior in patients and healthy controls. These studies are catalogued in large databases, amenable to quantitative meta-analysis techniques similar to those used for structural imaging [26] . Large databases of resting-state scans in >1000 individuals are also available for interrogation [27, 28] .
An emerging finding is that brain regions rarely act in isolation, but rather coordinate their activity into functional networks, each with a distinctive spatial map [29, 30] . These networks can be (ii) These three nodes belong to a common network of co-activating brain regions seen in meta-analyses of brain activation across multiple tasks; on resting-state activity, these nodes belong to a larger common network that also includes a circuit of connected regions in the striatum, thalamus, subthalamic nucleus, and brainstem. Adapted from [24] (A), [20] (B), and [25] (C).
extracted from ongoing brain activity, using seed-based or data-driven methods, and are consistent across individuals in the resting state [31] . Remarkably, a similar set of co-activating networks emerges from meta-analyses of brain activation during task performance [32] , suggesting a common functional architecture during either activation or rest. The exact number of networks is debated; recent studies across a set of 1000 healthy individuals found peaks of stability for seven-and 17-network parcellations of cortex [33] , with corresponding parcellations in striatum [27] and cerebellum [34] (Figure 3A, Key Figure) .
Some of these functional networks are restricted to low-level sensory or motor areas, such as primary motor cortex, primary visual cortex, or extra-striate cortex ( Figure 3B ). Others extend broadly across multimodal regions of the cortex, suggesting a more integrative role. The best known and most studied is the default-mode network (DMN) [35] . With nodes in the medial prefrontal cortex, posterior cingulate cortex, precuneus, and lateral parietal cortex, it has recognized functions for self-referential thinking [36] , recollection and prospection [37] , and mind wandering [38] . Although abnormalities in the structure and dynamics of this network have been described across a variety of neurological psychiatric illnesses [39] [40] [41] [42] [43] , it is notable that the 'core' regions from VBM meta-analyses of psychiatric illness lie outside the major foci of the DMN itself.
Another network appears to act in opposition to the introspective functions of the DMN, during 'extrospective' activities, such as task performance [44, 45] . The so-called 'task-positive network' (TPN) includes several subnetworks, such as the central executive network (CEN) [46] or frontoparietal network (FPN) [47] . The FPN comprises lateral prefrontal and intraparietal areas. Active during a variety of external-focus cognitive tasks involving working memory or attention, the FPN may act to control behavior from external cues, on an event-by-event basis [48] . Importantly, while the FPN is consistently active in a variety of 'general intelligence'-related tasks involving rule-based behavioral control using external cues [49, 50] , its nodes have essentially no overlap with any of the areas seen in VBM meta-analyses of psychiatric illness.
However, another subnetwork appears to be more closely related. This anterior cingulo-insular network (aCIN) can be reliably separated from the FPN and appears consistently in seven-and 17-network parcellations of functional activity [33] (Figure 3A,B) . Often designated as the 'salience network' [51] (Figure 3C ), its key nodes overlap almost precisely within the areas identified as the psychiatric 'core': the left and right anterior insula, and the dACC. Its subcortical components include a larger loop circuit encompassing specific regions of the striatum, globus pallidus, subthalamic nucleus, and thalamus, as well as the dopamine-rich substantia nigra and ventral tegmental area in the brainstem, and specific regions of the lateral cerebellum ( Figures 2C, 3C) . Thus, the psychiatric 'common core' maps strikingly well on to a specific member of the set of reliably identifiable functional networks of the human brain, the aCIN or 'salience network'. Therefore, it is worth examining the functions of this network in greater detail.
Common Core Functions: Cognitive Control and Response Selection
Meta-analytic tools (e.g., Neurosynth [52] ) are now available to mine databases of thousands of functional imaging studies for brain regions consistently activated for given cognitive function, or vice versa. Meta-analytic searches using the term 'salience network' reveal a set of areas that map closely on to the aCIN and the psychiatric 'common core', as noted above ( Figure 3C ). Yet, the aCIN can also be mapped more specifically on to one of the constructs of the Research Domain Criteria (RDoC) proposed by the National Institute of Mental Health [53] . The construct of 'cognitive control', and specifically the subconstruct of 'response selection', map strikingly well to the aCIN and common core ( Figure 3C ), suggesting that deficiencies in these functions are a common element across psychiatric disorders, notwithstanding their differences in other domains. Deficiencies in self-regulation of emotions, thoughts, and behaviors are indeed a hallmark of psychiatric illness, and are also consistent with what is known about the functions of the dACC and anterior insula. The dACC stands midway along a hierarchy of medial prefrontal regions (ranging from the medial frontopolar cortex anteriorly, to supplementary motor area posteriorly) that guide goal selection, thought selection, and action selection based on internal drives, as opposed to external cues [54, 55] . The dACC itself contains a posterior region for response selection, a middle region for decision (action) selection, and an anterior region for strategy selection [56] . Consistent with this role, the dACC region is active when choosing freely between two different cognitive tasks [57] , and during voluntary, internally cued modulation of emotional states [58] .
The insula contains multiple functional subregions, each characterized by different patterns of functional connectivity to the rest of the brain and different functional roles [59, 60] . For example, posterior insula regions link to low-level somatosensory cortices, and have a proposed lowerlevel role in 'interoception', or visceral sensory perception [61] ; ventral anterior insula regions are active in chemosensory functions and in mediating disgust [62] . One particular insula subregion, in dorsal anterior insula, maps well on to the aCIN's anterior insular node, appears in VBM metaanalyses of psychiatric illness [25] , and shows functional connectivity to the other aCIN nodes, including dACC, frontal opercula, anterior putamen, and mediodorsal thalamus [60] . This subregion has a role in linking external sensory stimuli to their associated emotional states [61] . Examples include activation for external stimuli that are salient or behaviorally relevant [63, 64] , aversive [65] , sad [66] , or fearful [58] .
The RDoC constructs of internally cued cognitive control and response selection may help unify the variety of more specific functions attributed to the dACC and dorsal anterior insula across the neuroimaging literature. For the dACC, these include conflict detection and error detection [67] , impulse regulation [68] , suppression of prepotent behavior and cognition [69] , the capacity for counterfactual thought that underlies theory of mind [70] , and the modulation of emotional responses to external stimuli [71] . For the anterior insula, these include activation during errors in task performance [72] , visual observations of another person in pain [73] , or visually signaled rejection during social interaction [74] . In broad terms, the dACC and dorsal anterior insula may serve two sides of the same function. Where the anterior insula may switch cognition and emotion states based on external sensory inputs, the dACC may serve a similar function based on internal states and cues.
This division of labor would be consistent with the broader functional architecture of the prefrontal cortex, in which a hierarchy of lateral regions guides complex behavior using external cues, while a corresponding and functionally interconnected hierarchy of medial regions serves analogous functions based on internal cues [75] . Within this hierarchy, the aCIN nodes would stand in a crossroads or 'hub' position, linking multiple networks mediating cognition and emotion [76] , thus having a prominent role across multiple psychiatric disorders. abnormality across psychiatric disorders. (C) The common neural substrates across multiple psychiatric illnesses on voxelbased morphometry (VBM) studies comprise a coherent functional network on resting-state functional connectivity (rsFC) mapping (i), corresponding closely to the aCIN (ii), which in turn corresponds closely to the set of regions emerging from Neurosynth meta-analyses of activations in neuroimaging studies of the salience network (iii), and more specifically of the Research Domain Criteria construct 'cognitive control' (iv) and response inhibition (v). (D) (i) In graph theoretical analyses of the functional architecture of the brain, the aCIN regions (shown in purple) stand in a 'crossroads' position, connecting to many other subcommunities. By contrast, other communities, such as low-level visual networks (blue), low-level sensorimotor networks (cyan), or even the DMN itself (red), are relatively self contained, tightly integrated within themselves but not widely connected to other communities. (ii) Quantitative measures of network centrality, such as the participation coefficient (left) and community density (right), are high in the nodes of the aCIN (dorsal anterior cingulate cortex and anterior insula), supporting the premise that these regions serve as 'hubs' or 'crossroads' regions within the functional architecture of the brain as a whole. Adapted from [33] (A) and [76, 78] 
(D).

A Neural Crossroads for Psychiatric Illness
It is now possible to analyze network architecture in a rigorous, quantitative way using the mathematical tools of graph theory [77] . Recent studies have applied graph theory to patterns of resting-state functional connectivity in the human brain, allowing us to both map the larger functional architecture of the human brain, and situate the major functional networks within this architecture [78] (Figure 3D ). Some networks, such as primary visual or sensorimotor networks, are tightly integrated but relatively self contained, having less direct interaction with the other networks of the brain. The DMN, despite its prominent place in brain function, is relatively self contained; similar to visual cortex, its nodes interact much more with each other than with other networks.
By contrast, the nodes of the aCIN do interact with a variety of other brain networks, and must be traversed for many trajectories of information flow over the network as a whole. By this criterion, the aCIN fulfills the definition of a 'crossroads' network [78] . Assessed quantitatively, the aCIN nodes have a higher participation coefficient and higher community density than the DMN or other networks, interacting with a broader selection of other brain networks [76] (Figure 3D) . Thus, the aCIN has been proposed to act as a switching system between the FPN and DMN, activating when brain activity transitions between one and the other [79] . By standing at a crossroads position between other brain networks, the nodes of the aCIN are better equipped to integrate the modular functions of the other, more 'clannish' networks into a coherent whole.
Functional disruption of the aCIN is apparent in a variety of psychiatric illnesses, including MDD [80] , PTSD [81] , and OCD [82] . Conversely, patients with structural lesions of nodes in the aCIN show impairment across a wider range of neuropsychological functions than do patients with lesions in the DMN [83] . This observation raises the question of whether treatments that restore the functioning of the aCIN might have particularly broad-spectrum benefits across psychiatric disorders, particularly in comorbid cases, by enhancing the general capacity for self-driven cognitive control and response inhibition.
Targeting the Common Core for Therapeutic Effect
Localizing the neural substrates of psychiatric disease is of limited practical use unless these substrates can be targeted effectively and selectively; a challenging proposition with medications or psychotherapy. However, anatomically targeted interventions are now more feasible thanks to a new, fast-evolving class of treatments: brain stimulation therapies (Box 1). The 'common core' areas in the dACC and anterior insula are notable for being both moderately deep (4-5 cm from the scalp surface, for both dACC and anterior insula) and moderately focal (2-3 cm in extent). We consider first the evidence that each technique can successfully engage the target regions, and then the evidence on whether targeting these areas does show therapeutic efficacy across a broad spectrum of psychiatric disorders, as predicted.
Convulsive Therapies: ECT and MST In electroconvulsive therapy (ECT), simulations using finite element modeling (FEM) [84] suggest that standard bitemporal montages achieve more than adequate penetration of the induced electrical field throughout the cranium. However, focality with ECT is poor and extends well beyond the common core areas. A bifrontal montage may more selectively target the anterior insula bilaterally, and a right unilateral montage may have similar effects unilaterally. Newer proposed montages [85] and finer titration of the current amplitude [86] may achieve still better focality over the anterior insula, or potentially the dACC. So far, however, no ECT montage or parameter set has been optimized specifically to target the cortical components of the 'core' brain regions. FEM simulations toward this end may be a fruitful direction for future study.
FEM simulations of magnetic seizure therapy (MST) [84, 86] suggest a desirable combination of moderate depth and moderate focality, in a favorable three-lobed 'left-centre-right' spatial distribution. In particular, a double-cone inductor placed over the lateral frontal lobes may be well situated to stimulate the dorsomedial prefrontal region encompassing the dACC. The MST literature to date is sparse, and the comparative efficacy of different MST montages has not yet assessed; neither has the full range of potential indications for MST been explored. However, the good concordance of MST fields with the 'common core' brain regions suggests that MST should be studied across a wider range of indications than is usual for ECT, such as SCZ. In general, ECT and MST montages optimized for the aCIN could theoretically prove helpful for other severe, debilitating psychiatric illnesses that are presently poor indications for convulsive therapies, such as refractory OCD, PTSD, or anxiety disorders.
Nonconvulsive Therapies: rTMS Most therapeutic repetitive transcranial magnetic stimulation (rTMS) studies to date, regardless of indication, have targeted dorsolateral prefrontal cortex (DLPFC) [87] . While DLPFC-rTMS achieves fair efficacy for MDD [88, 89] , efficacy in other psychiatric disorders is more modest [90] [91] [92] [93] . DLPFC regions do occur in aCIN/salience network maps (Figure 3) , albeit less consistently than dACC and anterior insula ( Figure 3C ). Therefore, future rTMS studies might explore whether targeting these other aCIN nodes might boost remission rates across a wider range of psychiatric disorders.
The electromagnetic fields of rTMS are subject to a trade-off between depth and focality [94] , so designing a coil to stimulate the dACC and anterior insula selectively is challenging. However, FEM simulations suggest that stimulation to the 4-5 cm depth of the dACC and anterior insula is feasible with commercially available double-cone [95] and helmet-shaped 'deep TMS' systems [96, 97] , assuming that some stimulation of neighboring regions is acceptable.
Several lines of evidence suggest that stimulation of the dACC is feasible. Double-cone rTMS can elicit lower limb movements when used to target primary motor cortex for the lower extremity, 4-5-cm from the scalp surface [98] . Dorsomedial prefrontal rTMS has also been Box 1. Non-Invasive Brain Stimulation Therapies Non-invasive brain stimulation techniques for treating psychiatric illness include older approaches, such as electroconvulsive therapy (ECT), as well as more recently approved methods, such as repetitive transcranial magnetic stimulation (rTMS), hybrid methods, such as magnetic seizure therapy (MST), and emerging methods, such as transcranial direct current stimulation (tDCS). Their more invasive counterparts include deep brain stimulation (DBS) and epidural cortical stimulation (EpCS). All are being used to treat an increasingly wide range of psychiatric illnesses, from mood and anxiety disorders to substance dependence, psychotic illness, OCD, and eating disorders ECT applies pulsed electrical currents of approximately 800 mA to the brain to induce a therapeutic generalized tonicclonic seizure. The technique is performed under brief general anesthesia, with muscle relaxation to avoid injury from convulsive movements. Common montages include bilateral stimulation over the temporal poles, right unilateral stimulation over the right parietal cortex and right temporal pole, or bifrontal stimulation with both electrodes over the frontal pole. In all cases, stimulation is fairly nonfocal and extends across much of the cerebrum; medial temporal stimulation is thought to be responsible for the retrograde amnesia that is a common ECT side effect. MST induces the seizures via a pair of large circular rTMS coils placed over the vertex or the frontal lobes; stimulation is more focal and penetrates approximately 5 cm from the scalp surface, sparing the medial temporal lobes. rTMS uses powerful, focused magnetic field pulses to induce lasting changes in brain activity. Stimulation coils may have a circular or figure of eight shape; 'deep TMS' coils use a helmet-shaped array of windings to reach structures >5 cm from the scalp surface. A typical course involves 20-30 sessions of stimulation. The dorsolateral prefrontal cortex (DLPFC) is the most common target in the literature to date, with therapeutic effects seen in MDD [88, 89] . Other psychiatric indications under exploration include anxiety disorders, such as PTSD [90] , OCD [93] , substance dependence [97] , eating disorders [91] , and some symptoms of SCZ [122] .
tDCS [and its variants, such as transcranial alternating current or random noise stimulation (tACS/tRNS)] use current amplitudes that are more than 100 times weaker than ECT, and do not produce action potentials. Anodal stimulation is considered excitatory; cathodal stimulation is considered inhibitory. A limited number of large trials of tDCS suggest some efficacy in MDD [123, 124] ; to date, these have exclusively targeted the DLPFC, with left anodal and right cathodal stimulation.
shown directly to activate the dACC on positron emission tomography (PET) [99] , to influence performance on the Stroop task, which recruits this area [100] , and to reduce impulsivity on the delay-discounting task [101] .
Although the most common target for therapeutic rTMS is the DLPFC, a series of recent studies has begun to demonstrate therapeutic efficacy for dorsomedial rTMS for MDD and BP [102, 103] , OCD [104] , refractory alcohol dependence [105] , ASD [106] , binge and purge behaviors in eating disorders [107] , and PTSD [108] . These diverse effects are in keeping with the involvement of the dACC across multiple categories of psychiatric illness.
Fewer rTMS studies have attempted to target the insula. Double-cone rTMS has been shown to alter the perception of cold stimuli when applied to the posterior insula [109] , suggesting feasibility. rTMS has also recently been used to target the anterior insular node of the aCIN specifically, with changes observed in the resting-state functional connectivity of this network both within itself and to the FPN [110, 111] . Deep TMS of the frontal operculum and anterior insula, using a helmet-shaped coil, has recently shown efficacy for nicotine dependence, when applied at high but not low frequency [97] (see Outstanding Questions).
Nonconvulsive Therapies: tDCS Despite its relatively low field strength, there is evidence that transcranial direct current stimulation (tDCS) may be capable of altering the excitability of structures at the depth of the dACC and anterior insula. For example, anodal tDCS targeting lower limb motor cortex (equivalent to the depth of dACC) has been shown to potentiate TMS-induced lower limb movements [112] . Anodal tDCS of the dorsomedial prefrontal cortex, neighboring the dACC, has recently been shown to improve inhibitory control of behavior [113] , and to reduce implicit negative bias towards racial outgroups [114] . Both findings suggest potential therapeutic utility for enhancing self regulation of cognition, emotion, and behavior.
Thus far, there is little proof-of-concept evidence available regarding the feasibility of anterior insular tDCS. FEM simulations support the potential feasibility of stimulating regions of equivalent or greater depth [115] , particularly using the multielectrode montages of high-definition tDCS [116] . Therapeutically, few studies of dACC-tDCS or anterior insular tDCS have been reported. However, tDCS targeting the nearby supplementary motor area has recently been reported to modulate OCD symptoms, with worsening symptoms after a course of cathodal stimulation and improvement of symptoms after anodal stimulation [117] . Given the favorable safety and tolerability profile of tDCS, future studies targeting the dACC and anterior insula in psychiatric illness should be given high priority.
Neurosurgical Approaches to Brain Stimulation: EpCS and DBS Epidural cortical stimulation (EpCS) is well suited to targeting the dACC and anterior insula focally and selectively, since the stimulation contacts can be placed directly upon the cortical surfaces of these targets. To date, this technique has not been applied to the anterior insula. However, EpCS has shown therapeutic effect when applied to the medial prefrontal cortex, just anterior to the dACC, in patients with MDD [118] . However, this study also applied EpCS electrodes to DLPFC. Since the efficacy of EpCS for refractory MDD has been called into question [119] , the most important implication vis à vis the 'core' for this technique might be in encouraging exploration of evidence-based targets other than the DLPFC, before dismissal of its therapeutic value in MDD [120] . Deep brain stimulation (DBS) may be better suited to targeting the subcortical components of the aCIN circuit rather than the dACC and anterior insula directly. As with its approved use in movement disorders, DBS electrodes targeting the striatum, globus pallidus, or thalamus would be expected to modulate the entire cortico-striatal-pallidal-thalamic loop through the target region, to therapeutic effect [121] . With accurate implantation, one would hypothesize broadspectrum effects across a variety of psychiatric symptom categories. Maps of resting and taskbased functional connectivity through the aCIN may offer suggestions for novel DBS implantation targets in severe psychiatric disease.
Concluding Remarks
The Cartesian divide between the 'functional' disorders of psychiatry and the 'organic' disorders of neurology may soon be ending. Quantitative meta-analyses, applied to growing repositories of neuroimaging data, are helping to localize the neuroanatomical substrates of psychiatric illness. Strikingly, a common circuit seems to unify most psychiatric disorders, and this circuit maps fairly neatly on to a specific network of brain regions: the aCIN. This network occupies a critical 'hub' position within the functional architecture of the brain, which may account for its prominence in complex functions involving cognition, emotion, behavioral regulation, social behavior, and theory of mind. When this hub network fails, the corollary could be severely disabling illness, even if the basic component functions of sensory perception and motor control remain intact.
The notion of psychiatric dysfunction as an organic 'illness' may challenge our intuitions. However, it need not challenge our progress in developing new treatments. The identification of a discrete set of neural substrates for psychiatric illness arrives at a fortuitous time, just as anatomically targeted brain stimulation therapies are making the leap from the lab to the clinic. Optimizing the efficacy of brain stimulation therapies requires that we engage the correct targets. As a result of a confluence of progress in neuroimaging and brain stimulation, we may soon be on the cusp of a new generation of more effective therapies in one of the most challenging, yet most exciting fields of modern medicine.
Outstanding Questions
Do lesion studies confirm VBM metaanalyses in implicating the aCIN, or other functional networks, in psychiatric illness? Large registries of patients with focal brain lesions (e.g., the Vietnam Head Injury Study registry) may be informative in bolstering evidence for a robust link between aCIN pathology and psychiatric symptomatology. Which brain stimulation techniques can offer reliable and focal stimulation of the dACC and anterior insula? Although focal stimulation of these areas (or their subcortical partners) may be possible with invasive techniques, such as DBS or EpCS, further research will be helpful to clarify how reliably and how selectively these areas can be stimulated with non-invasive techniques, such as tDCS, rTMS, MST, and ECT.
Which psychiatric illnesses will respond to stimulation of the dACC and anterior insula? Although promising results are emerging for some disorders, such as MDD, PTSD, OCD, and substance abuse, there remains a need for large, multicenter, randomized controlled trials to better establish the range of disorders for which 'common core' stimulation will prove to have therapeutic efficacy.
Which biomarkers are best suited for demonstrating engagement of the dACC and anterior insula targets during therapeutic brain stimulation? Neuroimaging, electrophysiological, cognitive, behavioral, or clinical-symptomatic measures may all be useful for demonstrating modulation of the target regions during treatment.
Can clinically useful biomarkers be developed for predicting and tracking treatment outcome in individual patients? Given that brain stimulation techniques themselves may be heterogeneous in their effects on individual patients, there is a need for biomarkers that can reliably predict and track treatment outcomes. To be clinically useful, these biomarkers must achieve adequate predictive accuracy (generally >85%) in individual patients, rather than simply correlating with outcomes across a sample of patients overall.
